Cargando…

Rational Drug Design of Axl Tyrosine Kinase Type I Inhibitors as Promising Candidates Against Cancer

The high level of Axl tyrosine kinase expression in various cancer cell lines makes it an attractive target for the development of anti-cancer drugs. In this study, we carried out several sets of in silico screening for the ATP-competitive Axl kinase inhibitors based on different molecular docking p...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarukhanyan, Edita, Shityakov, Sergey, Dandekar, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010640/
https://www.ncbi.nlm.nih.gov/pubmed/32117858
http://dx.doi.org/10.3389/fchem.2019.00920